Pfizer Inc.PFENYSE
Loading
Revenue PerformanceStable
Percentile Rank79
3Y CAGR-14.6%
5Y CAGR+8.5%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
-14.6%/yr
vs +16.9%/yr prior
5Y CAGR
+8.5%/yr
Recent deceleration
Acceleration
-31.5pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $62.58B | -1.6% |
| 2024 | $63.63B | +6.8% |
| 2023 | $59.55B | -40.6% |
| 2022 | $100.33B | +23.4% |
| 2021 | $81.29B | +95.2% |
| 2020 | $41.65B | +1.2% |
| 2019 | $41.17B | -23.3% |
| 2018 | $53.65B | +2.1% |
| 2017 | $52.55B | -0.5% |
| 2016 | $52.82B | - |